Prospectives for the use of nanomaterials in nanodiagnostic
Autor(a) principal: | |
---|---|
Data de Publicação: | 2014 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | https://actafarmaceuticaportuguesa.com/index.php/afp/article/view/45 |
Resumo: | Conventional diagnostic methods are exclusively focused on the detection of the symptoms associated to a given pathology. Any process able to determine with anticipation the occurrence of a disease, inclusively before the first symptoms, or providing the means to predict the possibility of occurrence of that disease, would significantly reinforce the effectiveness of the therapy allowing, at the same time, the establishment of prevention measures to avoid its progression. Much of the worldwide health research aims at the development of expedite devices or strategies capable of carrying out the monitoring of first level signs, or able to early detect and quantify biomarkers, usually at very low concentrations, associated to a given illness. In the search for alternative diagnostic methods able to overcome the limitations of available technology nanomaterials assume a decisive role and anticipate extremely promising developments in healthcare medicine. |
id |
RCAP_5fe54ca999b92a4c66f944567954455e |
---|---|
oai_identifier_str |
oai:ojs.actafarmaceuticaportuguesa.com:article/45 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Prospectives for the use of nanomaterials in nanodiagnosticPerspetivas de utilização de nanomateriais em nanodiagnósticoNanomedicinenanodiagnosticsnanomaterialsquantum dotsmetallic nanoparticlesNanomedicinananodiagnósticonanomateriaispontos quânticosnanopartículas metálicasConventional diagnostic methods are exclusively focused on the detection of the symptoms associated to a given pathology. Any process able to determine with anticipation the occurrence of a disease, inclusively before the first symptoms, or providing the means to predict the possibility of occurrence of that disease, would significantly reinforce the effectiveness of the therapy allowing, at the same time, the establishment of prevention measures to avoid its progression. Much of the worldwide health research aims at the development of expedite devices or strategies capable of carrying out the monitoring of first level signs, or able to early detect and quantify biomarkers, usually at very low concentrations, associated to a given illness. In the search for alternative diagnostic methods able to overcome the limitations of available technology nanomaterials assume a decisive role and anticipate extremely promising developments in healthcare medicine. Os métodos de diagnósticos convencionais estão exclusivamente empenhados na deteção de sintomas associados a uma dada patologia. Qualquer processo que permita determinar o mais antecipadamente possível a ocorrência da doença, inclusive antes de surgirem os primeiros indícios, ou que permita avaliar o risco da doença ocorrer, reforçaria significativamente as hipóteses de sucesso da terapia e tornaria até praticável tomar medidas preventivas para evitar a sua progressão. Muita da investigação em curso na área da medicina passa pelo desenvolvimento de estratégias ou dispositivos capazes de efetuar a monitorização, o mais antecipadamente possível, destes indícios, ou então capazes de detetar e quantificar precocemente marcadores biológicos, usualmente em concentrações muito baixas, associados a uma dada patologia. Na pesquisa por métodos de diagnósticos alternativos, aptos a ultrapassar algumas das limitações dos métodos atuais, os nanomateriais assumem um papel decisivo e abrem perspetivas de desenvolvimento extremamente promissoras para a área do nanodiagnóstico. Acta Farmacêutica Portuguesa2014-07-01T00:00:00Zjournal articleinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfapplication/pdfhttps://actafarmaceuticaportuguesa.com/index.php/afp/article/view/45oai:ojs.actafarmaceuticaportuguesa.com:article/45Acta Farmacêutica Portuguesa; v. 3 n. 1 (2014); 3-142182-3340reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporhttps://actafarmaceuticaportuguesa.com/index.php/afp/article/view/45https://actafarmaceuticaportuguesa.com/index.php/afp/article/view/45/54https://actafarmaceuticaportuguesa.com/index.php/afp/article/view/45/76Santos, João.M.Rodrigues, S.M.Ribeiro, D.M.Prior, J.V.info:eu-repo/semantics/openAccess2022-09-05T12:29:45Zoai:ojs.actafarmaceuticaportuguesa.com:article/45Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T14:59:54.110256Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Prospectives for the use of nanomaterials in nanodiagnostic Perspetivas de utilização de nanomateriais em nanodiagnóstico |
title |
Prospectives for the use of nanomaterials in nanodiagnostic |
spellingShingle |
Prospectives for the use of nanomaterials in nanodiagnostic Santos, João.M. Nanomedicine nanodiagnostics nanomaterials quantum dots metallic nanoparticles Nanomedicina nanodiagnóstico nanomateriais pontos quânticos nanopartículas metálicas |
title_short |
Prospectives for the use of nanomaterials in nanodiagnostic |
title_full |
Prospectives for the use of nanomaterials in nanodiagnostic |
title_fullStr |
Prospectives for the use of nanomaterials in nanodiagnostic |
title_full_unstemmed |
Prospectives for the use of nanomaterials in nanodiagnostic |
title_sort |
Prospectives for the use of nanomaterials in nanodiagnostic |
author |
Santos, João.M. |
author_facet |
Santos, João.M. Rodrigues, S.M. Ribeiro, D.M. Prior, J.V. |
author_role |
author |
author2 |
Rodrigues, S.M. Ribeiro, D.M. Prior, J.V. |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
Santos, João.M. Rodrigues, S.M. Ribeiro, D.M. Prior, J.V. |
dc.subject.por.fl_str_mv |
Nanomedicine nanodiagnostics nanomaterials quantum dots metallic nanoparticles Nanomedicina nanodiagnóstico nanomateriais pontos quânticos nanopartículas metálicas |
topic |
Nanomedicine nanodiagnostics nanomaterials quantum dots metallic nanoparticles Nanomedicina nanodiagnóstico nanomateriais pontos quânticos nanopartículas metálicas |
description |
Conventional diagnostic methods are exclusively focused on the detection of the symptoms associated to a given pathology. Any process able to determine with anticipation the occurrence of a disease, inclusively before the first symptoms, or providing the means to predict the possibility of occurrence of that disease, would significantly reinforce the effectiveness of the therapy allowing, at the same time, the establishment of prevention measures to avoid its progression. Much of the worldwide health research aims at the development of expedite devices or strategies capable of carrying out the monitoring of first level signs, or able to early detect and quantify biomarkers, usually at very low concentrations, associated to a given illness. In the search for alternative diagnostic methods able to overcome the limitations of available technology nanomaterials assume a decisive role and anticipate extremely promising developments in healthcare medicine. |
publishDate |
2014 |
dc.date.none.fl_str_mv |
2014-07-01T00:00:00Z |
dc.type.driver.fl_str_mv |
journal article info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://actafarmaceuticaportuguesa.com/index.php/afp/article/view/45 oai:ojs.actafarmaceuticaportuguesa.com:article/45 |
url |
https://actafarmaceuticaportuguesa.com/index.php/afp/article/view/45 |
identifier_str_mv |
oai:ojs.actafarmaceuticaportuguesa.com:article/45 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://actafarmaceuticaportuguesa.com/index.php/afp/article/view/45 https://actafarmaceuticaportuguesa.com/index.php/afp/article/view/45/54 https://actafarmaceuticaportuguesa.com/index.php/afp/article/view/45/76 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Acta Farmacêutica Portuguesa |
publisher.none.fl_str_mv |
Acta Farmacêutica Portuguesa |
dc.source.none.fl_str_mv |
Acta Farmacêutica Portuguesa; v. 3 n. 1 (2014); 3-14 2182-3340 reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799129871027273728 |